Clinical Trial Update: Study of Drug-drug Interaction of the Effects of Gemfibrozil and Rifampicin on SAR442168 in Healthy Adult Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating drug-drug interaction between gemfibrozil and rifampicin on SAR442168 pharmacokinetics in healthy adult subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Gemfibrozil (Gemfibrozil)
• Rifampicin
• SAR442168

Snippet

Sponsor: Sanofi | Conditions: Multiple Sclerosis | Phase 1 | Status: COMPLETED